S. Amat

750 total citations
15 papers, 592 citations indexed

About

S. Amat is a scholar working on Cancer Research, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, S. Amat has authored 15 papers receiving a total of 592 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Cancer Research, 11 papers in Pathology and Forensic Medicine and 10 papers in Oncology. Recurrent topics in S. Amat's work include Breast Cancer Treatment Studies (12 papers), Breast Lesions and Carcinomas (11 papers) and Cancer Treatment and Pharmacology (8 papers). S. Amat is often cited by papers focused on Breast Cancer Treatment Studies (12 papers), Breast Lesions and Carcinomas (11 papers) and Cancer Treatment and Pharmacology (8 papers). S. Amat collaborates with scholars based in France, Gabon and China. S. Amat's co-authors include P. Chollet, Frédérique Penault‐Llorca, J Dauplat, G. Le Bouëdec, H. Curé, M de Latour, M-A Mouret-Reynier, Achard Jl, V. Feillel and Fabrice Kwiatkowski and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

S. Amat

14 papers receiving 581 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
S. Amat France	9	413	384	209	86	72	15	592
EC Inwald Germany	6	260 0.6×	266 0.7×	109 0.5×	81 0.9×	114 1.6×	11	517
Masakazu Amari Japan	12	322 0.8×	230 0.6×	187 0.9×	144 1.7×	101 1.4×	25	531
Stacy Moulder-Thompson United States	8	237 0.6×	323 0.8×	53 0.3×	74 0.9×	335 4.7×	9	580
S O Emdin Sweden	7	220 0.5×	286 0.7×	125 0.6×	45 0.5×	169 2.3×	7	477
F Khandan Germany	7	295 0.7×	312 0.8×	88 0.4×	31 0.4×	122 1.7×	10	449
Mikhail Byakhov Russia	6	231 0.6×	221 0.6×	83 0.4×	29 0.3×	94 1.3×	19	385
Monica Jernberg Engstrøm Norway	11	242 0.6×	273 0.7×	79 0.4×	58 0.7×	147 2.0×	21	472
Greg Friberg United States	10	95 0.2×	189 0.5×	59 0.3×	50 0.6×	259 3.6×	15	488
J. Chakrabarti United Kingdom	6	137 0.3×	158 0.4×	39 0.2×	141 1.6×	202 2.8×	11	410
Beverly J. Lynch United States	7	111 0.3×	236 0.6×	190 0.9×	37 0.4×	172 2.4×	7	423

Countries citing papers authored by S. Amat

Since Specialization

Citations

This map shows the geographic impact of S. Amat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Amat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Amat more than expected).

Fields of papers citing papers by S. Amat

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Amat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Amat. The network helps show where S. Amat may publish in the future.

Co-authorship network of co-authors of S. Amat

This figure shows the co-authorship network connecting the top 25 collaborators of S. Amat. A scholar is included among the top collaborators of S. Amat based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Amat. S. Amat is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

1.

Huang, Shuwen, Yi Yang, Xia Zhang, et al.. (2025). Genome-Wide Analysis of Trehalose-6-Phosphate Phosphatases (TPP) Gene Family in Potato (Solanum tuberosum) Reveals Functional Divergence Under Stress. Plants. 14(21). 3300–3300.

2.

Baeyens, Luc, et al.. (2008). Small cell carcinoma of the ovary successfully treated with radiotherapy only after surgery: case report.. PubMed. 29(5). 535–7. 6 indexed citations

3.

Amat, S., Marie‐Ange Mouret‐Reynier, Frédérique Penault‐Llorca, et al.. (2006). Sequential Addition of an Anthracycline-Based Regimen to Docetaxel as Neoadjuvant Chemotherapy in Patients with Operable Breast Cancer. Clinical Breast Cancer. 7(3). 262–269. 3 indexed citations

4.

Abrial, Catherine, Marie‐Ange Mouret‐Reynier, S. Amat, et al.. (2005). Tumor Parameters, Clinical and Pathological Responses, Medical Management, and Survival Through Time on 710 Operable Breast Cancers. Medical Oncology. 22(3). 233–240. 5 indexed citations

5.

Abrial, Catherine, Isabelle Van Praagh, R. Delva, et al.. (2005). Pathological and Clinical Response of a Primary Chemotherapy Regimen Combining Vinorelbine, Epirubicin, and Paclitaxel as Neoadjuvant Treatment in Patients with Operable Breast Cancer. The Oncologist. 10(4). 242–249. 9 indexed citations

6.

Mouret‐Reynier, Marie‐Ange, Catherine Abrial, Jean-Pierre Ferrière, et al.. (2004). Neoadjuvant FEC 100 for Operable Breast Cancer: Eight-Year Experience at Centre Jean Perrin. Clinical Breast Cancer. 5(4). 303–307. 10 indexed citations

7.

Chollet, P., S. Amat, Bernard Leduc, et al.. (2004). Predictive and prognostic factors in patients treated by neoadjuvant chemotherapy: A retrospective study. Journal of Clinical Oncology. 22(14_suppl). 9702–9702. 1 indexed citations

8.

Penault‐Llorca, Frédérique, Anne Cayre, Florence Mishellany, et al.. (2003). Induction chemotherapy for breast carcinoma: predictive markers and relation with outcome. International Journal of Oncology. 22(6). 1319–25. 64 indexed citations

9.

Chollet, P., S. Amat, Ernest Bélembaogo, et al.. (2003). Is Nottingham prognostic index useful after induction chemotherapy in operable breast cancer?. British Journal of Cancer. 89(7). 1185–1191. 36 indexed citations

10.

Amat, S., Philippe Bougnoux, Frédérique Penault‐Llorca, et al.. (2003). Neoadjuvant docetaxel for operable breast cancer induces a high pathological response and breast-conservation rate. British Journal of Cancer. 88(9). 1339–1345. 80 indexed citations

11.

Chollet, P., S. Amat, H. Curé, et al.. (2002). Prognostic significance of a complete pathological response after induction chemotherapy in operable breast cancer. British Journal of Cancer. 86(7). 1041–1046. 207 indexed citations

12.

Curé, Hervé, S. Amat, Frédérique Penault‐Llorca, et al.. (2002). Prognostic Value of Residual Node Involvement in Operable Breast Cancer after Induction Chemotherapy. Breast Cancer Research and Treatment. 76(1). 37–45. 54 indexed citations

13.

Chollet, P., S. Amat, H. Curé, et al.. (2002). Prognostic significance of a complete pathological response after induction chemotherapy in operable breast cancer. British Journal of Cancer. 86(7). 1041–1046. 6 indexed citations

14.

Amat, S., Frédérique Penault‐Llorca, H. Curé, et al.. (2002). Scarff-Bloom-Richardson (SBR) grading: a pleiotropic marker of chemosensitivity in invasive ductal breast carcinomas treated by neoadjuvant chemotherapy. International Journal of Oncology. 20(4). 791–6. 83 indexed citations

15.

Filipski, Elisabeth, S. Amat, G Lemaigre, et al.. (1999). Relationship Between Circadian Rhythm of Vinorelbine Toxicity and Efficacy in P388-Bearing Mice. Journal of Pharmacology and Experimental Therapeutics. 289(1). 231–235. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact